“The intensive approach of CHAVI-ID will give us an excellent chance of accomplishing that.”

The goal of CHAVI-ID, Emory said, is “to accelerate HIV vaccine development by supporting multidisciplinary research into immune responses that prevent or contain HIV infection and by generating model vaccine components that can induce these protective immune responses.”

For more information, please visit http://www.whsc.emory.edu/home/about

Leave a Reply

Your email address will not be published.


− 7 = one